67 results
8-K
EX-2.1
SRNEQ
Sorrento Therapeutics, Inc.
22 Mar 19
Entry into a Material Definitive Agreement
7:00am
and Privacy
Section 2.27
Manufacturing
Section 2.28
Regulatory Filings
Section 2.29
Product Candidates
Section 2.30
OFAC
Section 2.31
Independent … . The Company has materially complied with all applicable contractual and legal requirements pertaining to data collection, use, privacy, protection
8-K
EX-2.1
SRNEQ
Sorrento Therapeutics, Inc.
20 Aug 20
Sorrento ENTERS INTO MERGER AGREEMENT TO ACQUIRE SmartPharM and About SmartPharm Therapeutics
4:55pm
2.27 Import/Export Control
2.28 Certain Payments
2.29 Personal Information and Privacy
2.30 Brokers; Other Service Providers
2.31 Complete Copies … and Laws pertaining to data collection, use, privacy, protection and security. No complaint relating to an improper use or disclosure of, or a breach
8-K
EX-2.1
SRNEQ
Sorrento Therapeutics, Inc.
18 Mar 22
Entry into a Material Definitive Agreement
9:01am
Compliance
5.29 Compliance with Health Care Laws and Certain Contracts
5.30 Insurance
5.31 Related Party Transactions
5.32 Privacy and Data Security
5.33 … (a)(viii).
1.73 �� “HIPAA” has the meaning set forth in the definition of “Privacy Laws.”
1.74 “HSR Act” means The Hart–Scott–Rodino Antitrust
425
EX-2.1
SRNEQ
Sorrento Therapeutics, Inc.
18 Mar 22
Business combination disclosure
9:03am
Compliance
5.29 Compliance with Health Care Laws and Certain Contracts
5.30 Insurance
5.31 Related Party Transactions
5.32 Privacy and Data Security
5.33 … (a)(viii).
1.73 �� “HIPAA” has the meaning set forth in the definition of “Privacy Laws.”
1.74 “HSR Act” means The Hart–Scott–Rodino Antitrust
8-K
EX-2.1
SRNEQ
Sorrento Therapeutics, Inc.
19 Jan 22
Entry into a Material Definitive Agreement
9:01am
or other data that, in either case, would otherwise give rise to any obligations on behalf of the Company under Privacy Requirements.
“Dollars” means … “personal data,” “personal information,” “personally-identifiable information,” or equivalent terms, as otherwise defined under Privacy Laws.
“Pre
8-K
EX-2.1
lpslfq7w
5 Apr 21
Sorrento eNTERS INTO MERGER agreement tO acquire late-stage oncology company acea therapeutics
9:11am
8-K
EX-2.1
t39fu bhp
3 Nov 23
Entry into a Material Definitive Agreement
5:31pm
8-K
EX-99.2
qqqqlaskxp9qcm7nc
20 Jun 23
Regulation FD Disclosure
5:01pm
8-K
EX-99.1
6dtdra1
10 Aug 23
Entry into a Material Definitive Agreement
4:14pm
424B5
awzlp
7 Oct 13
Prospectus supplement for primary offering
12:00am
424B5
xrezd0594qbm9fr yzp2
23 Oct 13
Prospectus supplement for primary offering
12:00am
424B5
zcmeu h0093
28 Oct 13
Prospectus supplement for primary offering
12:00am
8-K
EX-2.1
xw6h25cctlih hof9z8
10 Aug 23
Entry into a Material Definitive Agreement
4:14pm